CALLING THE COMPANION DIAGNOSTIC COMMUNITY Companion diagnostic regulation is critically challenging biopharma due to Europe's IVDR confusion, uncertainty about LDT reclassification, and fear around upcoming FDA updates. This summer, there’s one essential event to navigate these global regulatory changes, tackle reimbursement and policy issues, reduce submission risks, and ensure timely access to safe and effective companion diagnostics worldwide. Secure your spot in the room now at the World CDx Regulatory Affairs & Policy Summit to make sure you have a role in collaborating with key decision makers, influencing the policies that will shape CDx regulation & reimbursement indefinitely: https://ter.li/j2phi9 Jai Pandey, PhD, Vihanga Pahalawatta, Lori Roadcap, Andrea Renninger, Claudia Dollins Mary J. Savage, Deb Rasmussen, Ralph Riley, Dun Liang, Andrew L'Huillier, Sid Mathur, Qing Li, MD. PhD, Hannah O. Edward, Kaska (Katarzyna) Kowanetz, PhD, RAC, Brian Baker
This figures to be a critical event as the future of Precision Medicine continues to evolve.
CDx | Precision Medicine | Biomarkers | Rare diseases
6moWill the conference be face-to-face only or there will be an on-line broadcast?